About AVT
Browse Articles
Customer Services

Case report

Treatment of hepatitis C in two paediatric patients using sofosbuvir during haematopoietic stem cell transplantation

Antonio G Grasso, Aurelio Sonzogni, Davide Zanon, Alessandra Maestro, Stefano Loiacono, Natalia Maximova

Corresponding author name: Natalia Maximova
Corresponding author e-mail: natalia.maximova@burlo.trieste.it

Citation: Antiviral Therapy 2019; 24:603-607
doi: 10.3851/IMP3332

Date accepted: 17 June 2019
Date published online: 11 September 2019


We report the first two paediatric cases of sofosbuvir treatment during high-intensity myeloablative conditioning and engraftment phases of haematopoietic stem cell transplantation. These reports highlight the safety of sofosbuvir during all phases of transplantation and the lack of interaction between sofosbuvir and alkylating or immunosuppressive agents.


Copyright © 2020 Nucleus Holdings Ltd. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.